The waste management company posted earnings of $1.00 per share on revenue of $906.4 million for the fourth quarter.
Jim Cramer reviews the stocks of the S&P 500 to find out if they could run out of fuel in the new year.
A look at today's good, bad & ugly stocks, including Wells Fargo, Verizon and Stericycle.
With stocks at all-time highs, Matthew Roddy, Rockland Trust vice president, and Peter Andersen, Fiduciary Trust CIO, discuss their favorite stocks.
In a world of disappearing market returns and negative interest rates, the search for growth has become increasingly difficult, Goldman Sachs says.
Discussing the earnings forecast, and the way to play the market, with Scott Clemons, Brown Brothers Harriman, and Matthew Roddy, Rockland Trust.
CNBC's Susan Li takes a look at how the industrial sector fared after last week's Brexit vote.
Check out the companies making headlines after the bell Monday: Baidu, Square, Intuit and more.
Jim Cramer says ugly quarters from Macy’s and Nordstrom are a sign of a bigger cause of concern.
Each of these stocks have posted average gains in the five corrections prior to the current one. USA Today reports.
U.S. stocks closed near highs as investors focused on earnings beats amid progress towards near-term resolution in the Greek debt crisis.
Some of the names on the move ahead of the open.
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Stocks with low beta have led the latest leg of this bull market as volatility stayed low. That's reversing.
CNBC's Melissa Lee, Dominic Chu and contributor Herb Greenberg, preview the earnings for Pandora Media, Amazon and Stericycle.
CNBC contributor Herb Greenberg thinks investors should keep an eye on medical waste handler Stericycle, as well as environmental and chemical cleanup company Clean Harbor.
You can't make money from hoarding bottled water—yet. But you can make money by investing in the coming apocalypse. Here's how.
Check out which companies are making headlines after Monday's bell.
U.S. regulators, retailers and manufacturers are growing increasingly concerned that a surge in the number of products being recalled is resulting in "fatigue" by the public — increasing the chance that consumers could ignore or miss a recall that could ultimately endanger their health, USA Today reports.
The Lightning Round is extended in this CNBC.com exclusive feature.